These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13124503)

  • 1. An antithrombin reaction to prothrombin activation.
    Seegers WH; Johnson JF; Fell C
    Am J Physiol; 1954 Jan; 176(1):97-103. PubMed ID: 13124503
    [No Abstract]   [Full Text] [Related]  

  • 2. THE KINETICS OF THROMBIN ACTIVITY IN RECALCIFIED BLOOD PLASMA.
    GRANNIS GF; KAZAL LA; TOCANTINS LM
    Thromb Diath Haemorrh; 1965 Jun; 13():361-72. PubMed ID: 14347860
    [No Abstract]   [Full Text] [Related]  

  • 3. NEUTRALIZATION OF AUTOPROTHROMBIN C ACTIVITY WITH ANTITHROMBIN.
    SEEGERS WH; COLE ER; HARMISON CR; MONKHOUSE FC
    Can J Biochem; 1964 Mar; 42():359-64. PubMed ID: 14164282
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombin generation and formation of thrombin-antithrombin III complexes in congenital antithrombin III deficiency.
    Boyer C; Wolf M; Lavergne JM; Larrieu MJ
    Thromb Res; 1980 Oct; 20(2):207-18. PubMed ID: 7209877
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiological inhibitors of thrombin and thrombin synthesis].
    Schröer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(2):212-22. PubMed ID: 4122964
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in plasma prothrombin, Ac-globulin, and antithrombin concentration following intravenous administration of estrogens.
    JOHNSON JF
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):92-4. PubMed ID: 13400879
    [No Abstract]   [Full Text] [Related]  

  • 7. THE ACTION OF A PROTEOLYTIC ENZYME FROM ASPERGILLUS ORYZAE ON COMPONENTS OF THE BLOOD CLOTTING SYSTEM.
    MONKHOUSE FC; DARAMOLA F; GILLESPIE RJ
    Can J Physiol Pharmacol; 1964 Jul; 42():377-84. PubMed ID: 14324171
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in prothrombin and antithrombin in patients with thrombosing tendencies.
    HURN M; BARKER NW; MANN FD
    Am J Clin Pathol; 1947 Sep; 17(9):709-11. PubMed ID: 20265748
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the mechanism of heparin action by modification of its structure.
    Danishefsky I
    Fed Proc; 1977 Jan; 36(1):33-5. PubMed ID: 830555
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
    Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
    Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
    Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
    Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha 2-Macroglobulin remains as important as antithrombin III for thrombin regulation in cord plasma in the presence of endothelial cell surfaces.
    Ling X; Delorme M; Berry L; Ofosu F; Mitchell L; Paes B; Andrew M
    Pediatr Res; 1995 Mar; 37(3):373-8. PubMed ID: 7540283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRYOCOAGULOPATHY WITH PRESENCE OF IMMUNOANTITHROMBIN IN THE COURSE OF LUPUS ERYTHEMATOSUS DISSEMINATUS.
    STRUZIK T; HANICKI Z; HAWIGER J; BIERNACKA B
    Acta Med Pol; 1964; 5():61-80. PubMed ID: 14133809
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of prothrombinase at macroscopic lipid membranes: competition between antithrombin and prothrombin.
    Billy D; Speijer H; Lindhout T; Hemker HC; Willems GM
    Biochemistry; 1995 Oct; 34(41):13699-704. PubMed ID: 7577961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Abciximab on prothrombin activation and thrombin generation in acute coronary syndromes without ST-segment elevation: Global Utilization of Strategies to Open Occluded Coronary Arteries Trial IV in Acute Coronary Syndromes (GUSTO IV ACS) Italian Hematologic Substudy.
    Merlini PA; Repetto A; Lombardi A; Vetrano A; Fetiveau R; Cavallini C; Sappè D; Salvioni A; Canziani R; Savonitto S; Mannucci PM; Ardissino D
    Circulation; 2002 Feb; 105(8):928-32. PubMed ID: 11864920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.
    Ofosu FA; Fareed J; Smith LM; Anvari N; Hoppensteadt D; Blajchman MA
    Eur J Biochem; 1992 Jan; 203(1-2):121-5. PubMed ID: 1730217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin complex concentrates.
    Penner JA
    Bibl Haematol; 1977; 44():81-7. PubMed ID: 617787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.